Peer health navigator program improves access to affirming care for transgender individuals

Transgender and gender-diverse individuals often experience additional difficulties navigating health care.

Novel tool to predict a person’s risk for cardiovascular complications after bone marrow transplant

For thousands of Americans each year, a bone marrow transplant has the potential to cure diseases such as leukemias, lymphomas and immune deficiency disorders.

March 13, 2024

Synlogic’s phenylketonuria therapy gains FDA fast track status

Phenylketonuria is caused by inherited mutations that affect Phe disintegration. Credit: Saiful52 via Shutterstock.com. The US Food and Drug Administration (FDA) has awarded fast track designation to

July 12, 2023

SGN-1 by Guangzhou Huajin Pharmaceutical Technology for Melanoma: Likelihood of Approval

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

April 19, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.